Superworth

Pfizer forward PE PFE

Share price divided by analysts' consensus earnings for the next twelve months, since 1996.

Today, Oct 23, 2026
10.9×
10-year median
12.2×
Against its 10-year history
34th
percentile: 0 is its lowest day, 100 its highest
10-year range
8.0× to 74.0×
Peer median
18.8×

Pfizer's forward PE is 10.9× as of Oct 23, 2026.

That is below its ten-year median of 12.2×, lower than on 66% of days in the last ten years.

Over that time it ranged from 8.0× in Oct 2021 to 74.0× in Aug 2023.

The median for 8 large drugmakers of a similar size is 18.8×.

Forward PE over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far10.9×8.6×10.9×
20259.3×8.9×11.4×
202411.3×10.6×20.6×
202320.1×18.6×74.0×
202222.5×8.4×22.7×
202110.8×8.0×11.2×
202011.1×9.6×13.5×
201913.1×12.0×15.1×
201814.8×11.5×16.0×
201712.8×11.8×13.4×
201612.4×11.5×14.5×
201513.4×13.2×17.9×
201415.9×13.2×16.0×
201313.8×12.0×14.5×
201211.5×9.9×12.0×
201110.0×8.2×10.1×
20107.9×6.9×9.9×
20099.2×6.3×9.4×
20088.6×7.1×10.2×
20079.7×9.7×12.3×

Against its peers

Companies in Drug Manufacturers - General nearest Pfizer's size, closest first, today.

CompanyForward PE
PFEPfizer10.9×
GILDGilead Sciences17.2×
BMYBristol-Myers Squibb10.4×
AMGNAmgen18.6×
MRKMerck17.5×
ABBVAbbVie19.0×
JNJJohnson & Johnson23.4×
BIIBBiogen19.1×
LLYEli Lilly and33.9×
Peer median18.8×

Where Pfizer ranks

What the forward PE tells you

Price divided by what analysts expect the company to earn over the next twelve months. It answers "what am I paying for next year" instead of last year.

Estimates are opinions. When forward PE is far below trailing PE, analysts expect a big jump in earnings. If that jump slips, the stock was not as cheap as it looked.

More on Pfizer

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.